Activation of the TLR4/MyD88 Signaling Pathway Contributes to the Development of Human Hepatocellular Carcinoma via Upregulation of IL‑23 and IL‑17A

Oncology Letters - Greece
doi 10.3892/ol.2018.8586
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The IL-33/ST2 Axes Contributes to Hepatocyte Proliferation and Promotes Development of Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2018English

Regulatory Effects of C5a on IL-17A, IL-17F, and IL-23

Frontiers in Immunology
AllergyImmunology
2013English

Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB Signaling Pathway and an NLRP3 Inflammasome Activation

PLoS ONE
Multidisciplinary
2013English

LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2020English

IL-17A Promotes Cell Migration and Invasion of Glioblastoma Cells via Activation of PI3K/AKT Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

Jagged-1 Signaling Suppresses the IL-6 and TGF-β Treatment-Induced Th17 Cell Differentiation via the Reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1

Scientific Reports
Multidisciplinary
2015English

IL-17A and IL-17F Induce an Invasive Phenotype in Human Rheumatoid Synoviocytes Through the Same Signaling Pathway and the CXCR4/SDF1 Axis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

microRNA-519d Induces Autophagy and Apoptosis of Human Hepatocellular Carcinoma Cells Through Activation of the AMPK Signaling Pathway via Rab10

Cancer Management and Research
Oncology
2020English

A Novel TLR4-Mediated Signaling Pathway Leading to IL-6 Responses in Human Bladder Epithelial Cells

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy